:08045812163
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Erlotinib Tablets IP 150 Mg
4020 INR/Bottle
Product Details:
- Indication Non-Small Cell Lung Cancer, Pancreatic Cancer
- Dosage Form Tablet
- Salt Composition Erlotinib Hydrochloride IP
- Enzyme Types Enzyme Preparations
- Feature Dry Enzyme
- Ingredients Other
- Application Oral Administration for Cancer Therapy
- Click to view more
X
Erlotinib Tablets IP 150 Mg Price And Quantity
- 4020.00 - 4030.00 INR/Bottle
- 4020 INR/Bottle
- 10 Bottle
- 30 Tablets/Box
- Pregnancy, severe liver impairment
- 150 mg
- As directed by an oncologist
- IP Certified
- Oral
- Erlotinib-Tab-150-IP
- Alu-Alu Blisters
- Yes
- Keep out of reach of children.
- Film-coated
- Solid
- Registered Pharmaceutical Distributors
Erlotinib Tablets IP 150 Mg Product Specifications
- Oral Administration for Cancer Therapy
- Odorless
- Other
- Store below 30C, protected from moisture and light
- Erlotinib Hydrochloride IP
- Enzyme Preparations
- Non-Small Cell Lung Cancer, Pancreatic Cancer
- 24 months
- Tablet
- Dry Enzyme
- White to off-white tablets
- 30 Tablets/Box
- Pregnancy, severe liver impairment
- 150 mg
- As directed by an oncologist
- IP Certified
- Oral
- Erlotinib-Tab-150-IP
- Alu-Alu Blisters
- Yes
- Keep out of reach of children.
- Film-coated
- Solid
- Registered Pharmaceutical Distributors
Erlotinib Tablets IP 150 Mg Trade Information
- DELHI
- Cash Against Delivery (CAD), Cash on Delivery (COD), Letter of Credit (L/C), Days after Acceptance (DA), Letter of Credit at Sight (Sight L/C), Cash in Advance (CID), Cheque, Cash Advance (CA)
- 7 Bottle Per Day
- 7 Days
- Contact us for information regarding our sample policy
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
- CIPLA
Product Description
A drug called erlotinib Tablets IP 150 mg is used to treat specific cancers. The active component, erlotinib, is a type of tyrosine kinase inhibitor that inhibits certain proteins that encourage the proliferation of cancer cells. Professionals in medicine give these oral tablets for diseases like pancreatic cancer and non-small cell lung cancer. Depending on the health of the patient and their medical history, the 150 mg dosage is intended for personalized treatment. To ensure safe and efficient use, it is crucial to stick to the recommended dosage and the healthcare providers instructions.
Features of Erlotinib Tablets IP 150 Mg:
1. Erlotinib is a powerful drug that is used to treat some types of cancer, most notably non-small cell lung cancer and pancreatic cancer.
2. Tyrosine Kinase Inhibitor: It is a member of the group of drugs known as tyrosine kinase inhibitors that work by slowing the proliferation of cancer cells by blocking particular proteins.
3. Oral Administration: Because the pills are designed for oral administration, it is simple and straightforward to take them as prescribed by a healthcare professional.
4. Individualized Dosage: The 150 mg strength enables customized treatment based on the patients state and medical background, assuring the right course of treatment for each person.
5. Erlotinib is a form of targeted therapy that attacks cancer cells only, causing less harm to healthy cells and perhaps fewer side effects than conventional chemotherapy.
6. Longer Survival: Research indicates that erlotinib therapy prolongs survival.
Benefits of Erlotinib Tablets IP 150 Mg:
The usage of Erlotinib Tablets IP 150 mg should only occur under the supervision and prescription of a licensed healthcare provider, despite the fact that they may have some advantages. For the best possible treatment results, continuous monitoring and follow-up are essential. Individual responses to the medicine may differ.
FAQ:
1. What is the purpose of erlotinib tablets IP 150 mg?
Ans: The main conditions that Erlotinib Tablets IP 150 mg are used to treat include non-small cell lung cancer (NSCLC) and pancreatic cancer that has metastasized to other organs.
2. How do IP 150 mg erlotinib tablets function?
Ans: The kinase inhibitor drug class of medicines includes erlotinib Tablets IP 150 mg. It functions by preventing an individual protein (epidermal growth factor receptor, or EGFR), which is in charge of the growth and division of cancer cells.
3. How do I take 150 mg Erlotinib Tablets IP?
Ans: Take the 150 mg Erlotinib Tablets IP exactly as directed by your physician. It is typically taken once daily with a full glass of water, on an empty stomach, at least an hour before or two hours after a meal. Based on your unique condition, your doctor will give you precise advice.
4. What negative effects might Erlotinib Tablets IP 150 mg have?
Ans: Rash, diarrhea, nausea, vomiting, loss of appetite, lethargy, and gastrointestinal problems are some of the side effects of erlotinib tablets IP 150 mg.
Precise Cancer Therapy
Erlotinib Tablets IP 150 mg are designed for the oral treatment of advanced-stage non-small cell lung cancer and pancreatic cancer. This film-coated tablet ensures exact dosing and targeted therapy, improving the management of malignancies under specialist supervision.
Quality and Safety Assurance
Produced by registered pharmaceutical distributors, these tablets meet rigorous Indian Pharmacopoeia (IP) standards. The solid release form, odorless nature, and secure Alu-Alu blister packing ensure product integrity, safeguarded from light and moisture for up to 24 months.
FAQs of Erlotinib Tablets IP 150 Mg:
Q: How should I take Erlotinib Tablets IP 150 mg?
A: Take Erlotinib Tablets IP 150 mg exactly as prescribed by your oncologist, orally with water, at the recommended time and dosage. Do not modify or skip doses without consulting your healthcare provider.Q: What are the key indications for using Erlotinib Tablets IP 150 mg?
A: Erlotinib Tablets IP 150 mg are indicated for the treatment of non-small cell lung cancer and pancreatic cancer, as determined by your medical specialist.Q: When should Erlotinib Tablets IP 150 mg not be used?
A: Do not use Erlotinib Tablets IP 150 mg during pregnancy or if you have severe liver impairment, as these are contraindications for this medication. Always inform your healthcare provider about your medical history prior to use.Q: Where should I store Erlotinib Tablets IP 150 mg?
A: Store these tablets below 30C, protected from moisture and light, in their original Alu-Alu blister packaging. Keep them out of reach of children.Q: What process ensures the quality of Erlotinib Tablets IP 150 mg?
A: Erlotinib Tablets IP 150 mg are manufactured and marketed by registered pharmaceutical distributors in India, adhering to IP certification standards and strict quality control protocols.Q: What are the benefits of using Erlotinib Tablets IP 150 mg for cancer therapy?
A: Under oncologist supervision, Erlotinib Tablets IP 150 mg provide a targeted enzyme therapy that interferes with cancer cell growth, potentially improving disease management and patient outcomes.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Injection' category
"Our export market include Kenya, Oman, Dubai, Vietnam, Philippines, Hong Kong, Nigeria, Yemen, Ethiopia."
Contact Us
- Office: No -103, 1st Floor, Plot No C-1/A, (Plot No-1), Block -C, KH No-456, Sikka MS Chamber Aurna Park, Laxmi Nagar,Delhi - 110092, India
- Phone :08045812163
- Send Inquiry
Send Inquiry
- Mr Balraj Singh Negi (Director)
- Mobile :08045812163
|
 |
BIOGEN INDIA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |
